Discover 4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-one
A vital intermediate for advanced pharmaceutical research and VEGFR2 imaging agent development.
Get a Quote & SampleProduct Core Value
4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-one
This compound serves as a critical building block in the complex landscape of pharmaceutical synthesis. Its unique chemical structure makes it invaluable for developing targeted therapies and diagnostic agents, particularly in oncology.
- Explore the pharmaceutical synthesis intermediate applications of this high-purity compound.
- Understand the detailed properties of CAS 196603-96-0, including its physical and chemical characteristics.
- Learn about its role in the synthesis of potential VEGFR2 PET imaging agents for enhanced cancer diagnostics.
- Source this essential chemical intermediate from reliable global suppliers for your research needs.
Key Advantages
Exceptional Purity
Ensuring >98.0% purity, this compound meets stringent research requirements, critical for reproducible results in pharmaceutical synthesis.
Therapeutic Potential
Its application as a VEGFR2 PET imaging agent intermediate opens doors for advanced cancer patient imaging and treatment monitoring.
Versatile Building Block
As a key organic synthesis building block, it facilitates the creation of novel molecular structures with therapeutic significance.
Key Applications
Oncology Diagnostics
Utilized in the synthesis of agents for PET imaging of VEGFR, aiding in the visualization and study of cancer-related pathways.
Drug Discovery
Serves as a crucial intermediate in the development of new pharmaceutical compounds, contributing to the discovery of novel treatments.
Medicinal Chemistry
A valuable component in medicinal chemistry research for creating complex molecules with potential biological activity.
Research & Development
Essential for academic and industrial R&D focused on advanced organic synthesis and the creation of cutting-edge chemical entities.